-
Symbol
-
DNTH on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.001 per share
-
Latest Disclosed Shares Owned
-
1,315,892 shares
-
Security Ownership %
-
3.1%
BCLS Fund III Investments, LP ownership in Dianthus Therapeutics, Inc. /DE/ Common Stock, par value $0.001 per share (DNTH)
14 Nov 2025 - BCLS Fund III Investments, LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,315,892 shares of Dianthus Therapeutics, Inc. /DE/ Common Stock, par value $0.001 per share (DNTH).
This represents 3.1% ownership of the company.
In their previous filing dated 14 Aug 2025, BCLS Fund III Investments, LP had reported owning 2,482,250 shares, indicating a decrease of +47%.
.